Pfizer, BioNTech Covid-19 vaccines granted FDA fast track status

23 Aufrufe
Pfizer and BioNTech SE were granted fast track designation by the FDE for two of the companies’ four vaccine candidates against the coronavirus. Pfizer shares added 2%. BioNTech added 5%. CNBC's Joe Kernen breaks down the news and what it means for the market. Subscribe to CNBC PRO for access to investor and analyst insights and more:

» Subscribe to CNBC TV:
» Subscribe to CNBC:
» Subscribe to CNBC Classic:

Turn to CNBC TV for the latest stock market news and analysis. From market futures to live price updates CNBC is the leader in business news worldwide.

Connect with CNBC News Online
Get the latest news:
Follow CNBC on LinkedIn:
Follow CNBC News on Facebook:
Follow CNBC News on Twitter:
Follow CNBC News on Instagram:

Gesundheits Tipps
Kommentare deaktiviert.